Description

Clodia (Clopidogrel) Coated Tablets 75 mg. №30

Ingredients:

Each tablet contains 75 mg of clopidogrel as the active ingredient.

Mechanism of Action:

Clopidogrel, the active ingredient in Clodia tablets, is a platelet aggregation inhibitor that works by irreversibly binding to the P2Y12 receptor on platelets, preventing platelet activation and aggregation.

Pharmacological Properties:

Clopidogrel exerts its antiplatelet effects by inhibiting platelet activation and aggregation, thus reducing the risk of thrombotic events.

Indications for Use:

Clodia tablets are indicated for the prevention of blood clots in patients with a history of recent heart attack or stroke.

Contraindications:

Do not use Clodia if you have a history of bleeding disorders or if you are allergic to clopidogrel.

Side Effects:

Common side effects of clopidogrel include bruising, bleeding, and gastrointestinal discomfort. If you experience any unusual symptoms, seek medical attention immediately.

Usage Instructions:

The recommended dosage is one 75 mg tablet daily, taken orally with or without food. Follow the instructions provided by your healthcare provider. Do not exceed the recommended dosage.

Benefits Compared to Analogues:

Clopidogrel has shown efficacy in reducing the risk of cardiovascular events such as heart attacks and strokes, with studies demonstrating its superiority over other antiplatelet agents like aspirin.

Suitable Patient Groups:

Clodia tablets are suitable for adult patients with a history of recent heart attack or stroke. Consult a healthcare provider for use in specific patient populations such as children or the elderly.

Storage Conditions and Shelf Life:

Store Clodia tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product beyond the stated shelf life.

Packaging Description:

Clodia tablets are available in packages containing 30 coated tablets, each tablet marked with the dosage strength.

Clinical Evidence and Proven Effectiveness:

Several studies have demonstrated the efficacy of clopidogrel in reducing the risk of cardiovascular events such as heart attacks and strokes. The CAPRIE trial showed a significant reduction in the combined risk of ischemic stroke, myocardial infarction, or vascular death with clopidogrel compared to aspirin.